Vinflunine (VFL) in combination with carboplatin (CBDCA) for treatment of advanced non-small cell lung cancer (NSCLC) in chemonaive patients (pts): Phase I and pharmacokinetic study

被引：1
|
作者：
Robinet, G
Afenjar, K
Gouva, S
Planchard, D
Zorza, G
Tourani, J
机构：
[1] Hop Morvan, Brest, France
[2] Inst Rech Pierre Fabre, Boulogne, France
[3] CHU La Miletrie, Poitiers, France
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81059-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [21] Phase I/II study of bexarotene in combination with weekly paclitaxel monthly cartioplatin for the treatment of patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Beggs, V
    Disalvo, WM
    Dragnev, K
    Rigas, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 705S - 705S
  • [22] Vinorelbine (VNR)-cisplatin (CDDP)-carboplatin (CBDCA) combination in locally advanced or metastatic non-small cell lung cancer (NSCLC) plus phase II study
    Zylberait, D
    Charvolin, P
    Bernabeu, L
    Dumont, P
    Fallouh, H
    Biville, F
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 98
  • [23] Weekly docetaxel (TXT) and cisplatin (CIS) for chemonaive patients (Pts) with advanced non-small cell lung cancer (NSCLC)
    Aisner, J
    Geunsch, L
    Schwarz, S
    Zheng, L
    Wojtaszek, C
    Lutzker, S
    LUNG CANCER, 2005, 49 : S233 - S233
  • [24] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer
    Fedyanin, M.
    Tjulandin, S.
    Cheporov, S.
    Vladimirov, V.
    Moiseenko, V.
    Orlov, S.
    Manikhas, G.
    Koryakova, A.
    Cakana, A.
    Phelps, C.
    Baranovsky, S.
    Azarova, V.
    Karavaeva, O.
    Vostokova, N.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S96 - S96
  • [26] Effect of genetic polymorphisms on survival and toxicity in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with Carboplatin (CBDCA) and Alimta regimen
    Ludovini, Vienna
    Chiari, Rita
    Pistola, Lorenza
    Floriani, Irene
    Meacci, Marialuisa
    Minotti, Vincenzo
    Garavaglia, Daniela
    Tofanetti, Francesca R.
    Flacco, Antonella
    Mare, Marzia
    Giuffrida, Dario
    Crino, Lucio
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S901 - S901
  • [27] Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer
    Isamu Okamoto
    Masaki Miyazaki
    Ryotaro Morinaga
    Hiroyasu Kaneda
    Shinya Ueda
    Yoshikazu Hasegawa
    Taroh Satoh
    Akira Kawada
    Masahiro Fukuoka
    Koichi Fukino
    Takahiko Tanigawa
    Kazuhiko Nakagawa
    Investigational New Drugs, 2010, 28 : 844 - 853
  • [28] Pharmacokinetic (PK) analysis of a phase I study of continuous oral treatment with the angiokinase inhibitor BIBF 1120, in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer (NSCLC)
    Camidge, D. R.
    Conkling, P.
    Stephenson, J. J.
    Glassman, P. M.
    Zhao, Y.
    Kaiser, R.
    Stopfer, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] Phase II and pharmacogenetic study of docetaxel (D) and capecitabine (C) in chemonaive non-small cell lung cancer (NSCLC) patients (pts)
    Lustberg, M. B.
    Bekaii-Saab, T. S.
    Diasio, R.
    Ezzeldin, H.
    Starrett, S. L.
    Otterson, G. A.
    Villalona, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Phase I/II study of bortezomib in combination with carboplatin and bevacizumab as first line therapy in patients with advanced non-small cell lung cancer (NSCLC)
    Piperdi, Bilal
    Bradley, Kendra J.
    Bathini, Venu
    Zekos, Colleens M.
    Hanrahan-Boshes, Meredith
    Walsh, William V.
    CANCER RESEARCH, 2010, 70
12345